Effects of Ketone Supplementation on Acute Alcohol Withdrawal
Enrolling by invitation · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Alcohol Use Disorder, Alcohol Withdrawal, Alcohol Dependence, Ketosis
In brief
The goal of this study is to study the effects of the ketone supplement Kenetik compared to placebo (an inactive beverage) on alcohol withdrawal symptoms during the 5 days of clinical alcohol withdrawal management treatment at the Caron Treatment Center.
Key facts
- Study ID
- NCT06173973
- Run by
- University of Pennsylvania
- People needed
- 50
- Starts
- 2024-03-11
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meets current DSM-5 criteria for AUD and admitted for alcohol withdrawal management treatment at Caron Treatment Center
- Willingness to provide signed, informed consent and commit to completing the procedures in the study
You may not qualify if…
- Current, gastrointestinal (GI), liver or other clinically significant physical disease that may interfere with the intake of the Ketone Supplement based on medical history, and evaluation of the Study Physician.
- Currently pregnant or lactating, based on urine pregnancy test and clinical exam.
- Current significant withdrawal from other substances, including benzodiazepines, opioids that require medication management for withdrawal and may interfere with study results/withdrawal management plan.
- Judged by the principal investigator, Study Physician, or their designee to be an unsuitable candidate for the study.
Where it is running
- University of Pennsylvania Center for Studies of Addiction — Philadelphia, Pennsylvania, United States
- Caron Treatment Center — Wernersville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.